Migraine drug race turns its final corner, FDA decisions in sight

Nature Biotechnology 36, 207 (2018).
doi:10.1038/nbt0318-207

Author: Elie Dolgin

Source: Nature Biotechnology - March 6, 2018 Category: Biotechnology Authors: Elie Dolgin Tags: News Source Type: research